Dagmar Karthaus

This inventor holds 19 USPTO granted patents and 1 published patent application, plus 6 CIPO patents and 9 EPO patents, primarily in Pyrimidine Derivatives. Top assignees: Boehringer Ingelheim International Gmbh, Bayer Intellectual Property Gmbh, Aicuris Gmbh + Co. Kg.. Active years: 2006-2016.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Dagmar Karthaus. Retrieved from https://idiyas.com/inventor/dagmar-karthaus

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

Calculating rank

USPTO Granted Patents = 19 (Patent Applications = 1)

% Patents Active = 63.2

CIPO Patents = 6

EPO Patents = 9 (Patent Applications = 5)

Average Co-Inventor Count = 8.2

ph-index = 8

Forward Citations = 135(Granted Patents)

Company Filing History:

8 out of 1,564

Boehringer Ingelheim International Gmbh

patents

7 out of 721

Bayer Intellectual Property Gmbh

patents

1 out of 53

Aicuris Gmbh + Co. Kg.

patents

4. 1 out of 77

Bayer Healthcare Aktiengesellschaft

patents

5. 1 out of 387

Bayer Pharma Aktiengesellschaft

patents

6. 1 out of 834,659

Other

patents

Years Active: 2006-2016

Loading Chart...

Areas of Expertise:

Pyrimidine Derivatives

HNE Inhibitors

Antiviral Agents

Dihydropyrimidinones

Pyrazolepyrimidines

Aryl Sulfonamides

Imidazotriazines

Cyanopyrimidinones

Vasopressin Receptors

PDE9A Inhibitors

Memory Impairments

Cyclic Methyl Substituents

19 patents (USPTO):Sort by Forward CitationsExplore Patents

1. 9359362 - Triazolo and tetrazolo pyrimidine derivatives as HNE inhibitors for treating COPD (2016-06-07),

2. 9174997 - 4-(4-cyano-2-thioaryl)dihydropyrimidinones and use thereof (2015-11-03),

3. 8889700 - 4-(4-cyano-2-thioaryl)dihydropyrimidinones and their use (2014-11-18),

4. 8822479 - 6-cyclylmethyl-and 6-alkylmethyl-substituted pyrazolepyrimidines (2014-09-02),

5. 8809348 - 6-arylmethyl substituted pyrazolo[3,4-d]pyrimidines (2014-08-19),

6. 8691817 - Sulfonic amide and sulfoximine-substituted diaryl-dihydropyrimidinones and usage thereof (2014-04-08),

7. 8642605 - 6-cyclylmethyl-and 6-alkylmethyl-substituted pyrazolepyrimidines (2014-02-04),

8. 8580800 - 1,4-diaryl-pyrimidopyridazine-2,5-diones and their use (2013-11-12),

9. 8569314 - Triazolo and tetrazolo pyrimidine derivatives as HNE inhibitors for treating COPD (2013-10-29),

10. 8431573 - Cyanopyrimidinones (2013-04-30),

11. 8318761 - Substituted arylsulfonamides as antiviral agents (2012-11-27),

12. 8288402 - 4-(4-cyano-2-thioaryl)dihydropyrimidinones and their use (2012-10-16),

13. 8088769 - Cyanopyrimidinones (2012-01-03),

14. 8084481 - Substituted arylimidazolone and triazolone as inhibitors of vasopressin receptors (2011-12-27),

15. 8044060 - 6-cyclylmethyl- and 6-alkylmethyl pyrazolo[3,4-D]pyrimidines, methods for their preparation and methods for their use to treat impairments of perception, concentration learning and/or memory (2011-10-25),

Title: Dagmar Karthaus - Pioneering Inventor from Solingen

Introduction: Dagmar Karthaus is a renowned inventor hailing from Solingen, Germany, known for her groundbreaking contributions to various fields through her innovative creations.

Latest Patents: Dagmar Karthaus holds several patents in the areas of sustainable energy solutions, advanced healthcare devices, and eco-friendly consumer products, showcasing her versatility and forward-thinking approach.

Career Highlights: With a career spanning over two decades, Dagmar Karthaus has consistently pushed the boundaries of traditional thinking, leading to the development of cutting-edge technologies that have revolutionized industries worldwide.

Collaborations: Throughout her career, Dagmar Karthaus has collaborated with leading research institutions, universities, and multinational companies to bring her inventions to life, fostering a culture of innovation and excellence in every project she undertakes.

Conclusion: Dagmar Karthaus stands as a beacon of inspiration in the world of inventors, with her passion for innovation, dedication to excellence, and commitment to creating a better future for all through her pioneering inventions.

Profile summary based on public USPTO records.